---
id: 20260812-T0-09
title: "Chai Discovery今夏达成4笔交易，BioAI工具受制药业青睐"
title_en: "Chai Discovery Closes 4 BioAI Deals This Summer"
url: https://ai.daily.yangsir.net/daily/20260812-T0-09
issue_date: 2026-08-12
publish_date: 2026-08-11T21:03:50.000Z
category: news
source_name: "Latent Space"
source_url: https://www.latent.space/p/chai-discovery
---

# Chai Discovery今夏达成4笔交易，BioAI工具受制药业青睐

制药行业突然开始为Bio×AI工具付费，而Chai Discovery在这个夏天已经达成了四笔交易，处于领先地位。联合创始人Matt McPartlon和产品负责人Neil Patil解释了原因。这显示出AI在生物医药领域的商业化应用正在加速，制药公司愿意为能带来实际价值的AI工具买单。

## English Version

**Chai Discovery Closes 4 BioAI Deals This Summer**

The pharmaceutical industry is suddenly paying for Bio×AI tools, with Chai Discovery leading the pack after closing four deals this summer. Co-founder Matt McPartlon and Product leader Neil Patil explain why. This signals accelerating commercialization of AI in biopharma, with drug companies willing to pay for AI tools that deliver tangible value.

---

**来源**：[Latent Space](https://www.latent.space/p/chai-discovery)

**详情页**：https://ai.daily.yangsir.net/daily/20260812-T0-09

---

*智语观潮 · Daily — https://ai.daily.yangsir.net/llms.txt*